Related Experiment Videos
[Calcium channel blockers in the elderly with hypertension]
J R M'Buyamba Kabangu1, D Lusamba Dikassa
1Département de Médecine Interne, Université de Kinshasa (Unikin), Zaïre.
Insights
Calcium entry blockers (CEB) effectively lower blood pressure in older adults, offering a safe alternative to diuretics for managing geriatric hypertension. Further research is needed to confirm their impact on long-term health outcomes.
Area of Science:
- Gerontology
- Cardiovascular Pharmacology
- Internal Medicine
Background:
- Elderly hypertension management presents unique challenges.
- Traditional antihypertensives like diuretics may have limitations in geriatric patients.
- Calcium entry blockers (CEB) are a class of antihypertensive agents.
Purpose of the Study:
- To evaluate the efficacy and safety of calcium entry blockers (CEB) as a monotherapy for hypertension in the elderly.
- To compare the blood pressure-lowering effects of CEB with other antihypertensive agents in aged populations.
- To explore the potential reasons for CEB effectiveness in older individuals.
Main Methods:
- Review of existing literature on CEB use in geriatric hypertension.
- Analysis of pharmacokinetic and pharmacodynamic considerations in the elderly.
- Comparison of CEB efficacy against other antihypertensive drug classes.
Main Results:
- Calcium entry blockers (CEB) demonstrate effective blood pressure reduction when administered alone in the aged.
- CEB exhibit a similar blood pressure-lowering action compared to other antihypertensive drugs.
- CEB possess a favorable metabolic profile and are as safe in the elderly as in younger patients.
- Potential contributing factors to CEB effectiveness include elevated baseline blood pressure and altered physiological states in old age.
Conclusions:
- Calcium entry blockers (CEB) are effective antihypertensive agents for the elderly and can serve as alternatives to diuretics, especially when contraindicated.
- CEB appear safe and well-tolerated in the geriatric population.
- Further clinical trials are necessary to establish the definitive benefits of CEB on mortality, morbidity, and quality of life in geriatric hypertension.
Abstract:
Administered alone, calcium entry blockers (CEB) are effective antihypertensive agents in the aged, and their blood pressure lowering action is similar to that of other antihypertensive drugs. CEB may be regarded as alternatives to diuretics in the elderly, and they should be used instead of diuretics when these are contraindicated. The effectiveness of CEB might be explained by some characteristics of old age, such as elevated mean blood pressure, reduced plasma renin activity, blunted sympathetic activity, altered drug pharmacokinetics and so forth. CEB appear to have a favourable metabolic profile and to be as safe in the elderly as in younger patients. The beneficial effects of CEB on mortality, morbidity and quality of life in geriatric hypertension still need to be established.